What the Pure Food and Drug Act Was and Why It Mattered

The Pure Food and Drug Act was a landmark federal law signed on June 30, 1906, that made it illegal to sell adulterated or mislabeled food and drugs across state lines. It was the first major U.S. law to regulate what Americans ate and the medicines they bought, and it laid the foundation for what eventually became the Food and Drug Administration.

Why the Law Was Needed

In the late 1800s and early 1900s, the American marketplace was essentially unregulated. Manufacturers could put almost anything in food products: chemical preservatives, toxic dyes, fillers that disguised spoiled ingredients, and substances that were outright dangerous. “Patent medicines,” sold with bold promises to cure everything from headaches to cancer, routinely contained alcohol, opium, cocaine, and heroin without disclosing any of it on the label. Consumers had no reliable way to know what they were swallowing.

Dr. Harvey Washington Wiley, chief chemist at the U.S. Department of Agriculture, spent more than two decades pushing for federal regulation. He organized studies in which young volunteers ate measured doses of common food preservatives like borax and formaldehyde so researchers could document the health effects. These experiments, widely covered by the press and nicknamed the “Poison Squad,” helped build public outrage. Wiley also assembled a broad coalition of scientists, women’s organizations, and state food officials to lobby Congress. His efforts earned him the title “Father of the Pure Food and Drugs Act.”

The final push came in 1906, when Upton Sinclair published The Jungle, a novel exposing horrific conditions in Chicago’s meatpacking plants. Public disgust over the descriptions of contaminated meat gave Congress the political momentum to pass both the Pure Food and Drug Act and a companion law, the Meat Inspection Act, that same year.

What the Law Actually Did

The act targeted two core problems: adulteration and misbranding. A food was considered adulterated if it contained injurious mixtures, cheap substitutes for valuable ingredients, concealed damage or spoilage, or any filthy or decomposed substance. Confectionery specifically could not contain mineral substances, poisonous colors or flavors, or narcotics. Drugs were held to recognized standards of strength, quality, and purity; if a drug differed from those standards, the specific variations had to be clearly stated on the label.

Misbranding covered a wider range of deception. A product was misbranded if it imitated another product, used a false name, or carried a misleading label. Food packages had to be marked with their weight. Most significantly for the patent medicine industry, labels could not be false or misleading in any way, and the presence and amount of eleven dangerous ingredients, including alcohol, heroin, and cocaine, had to be listed. This was a direct strike at the “secret formula” business model that had allowed manufacturers to sell addictive substances disguised as health remedies.

How It Was Enforced

Enforcement fell to the Bureau of Chemistry within the Department of Agriculture, led by Wiley himself. The bureau hired the country’s first federal food and drug inspectors to complement its laboratory scientists, and together they launched an inspection program that, by the FDA’s own account, revolutionized the country’s food supply within the first decade. Under Wiley’s leadership, the bureau’s staff grew from 110 to 146 between 1906 and 1912, and its budget jumped from $155,000 to nearly $964,000 in the same period.

The early years were not smooth. Wiley clashed with the Secretary of Agriculture over preservative chemicals that the law hadn’t specifically addressed. Disputes over saccharin, bleached flour, caffeine, and benzoate of soda all had to be settled in court. The Secretary even appointed a separate board of scientists to repeat Wiley’s preservative experiments, effectively undermining his authority. Wiley eventually resigned in 1912, frustrated by the political resistance to aggressive enforcement.

Major Loopholes and Weaknesses

The 1906 act was groundbreaking, but it had serious gaps. The most damaging one involved therapeutic claims. In 1911, the Supreme Court ruled that the law did not apply to false claims about what a drug could cure, partly because the court believed medical knowledge itself was too uncertain for the government to regulate. This meant a manufacturer could slap “cures cancer” on a bottle of sugar water and face no penalty.

Congress tried to fix this in 1912 with the Sherley Amendment, which made it illegal to sell drugs the manufacturer knew to be worthless. But the word “knew” created its own loophole: prosecutors had to prove the manufacturer intended to commit fraud, which was extremely difficult in court. As a result, many dangerous products claiming to treat diabetes, cancer, and other serious diseases stayed on store shelves for years.

The law also applied only to products shipped across state lines. Anything manufactured and sold within a single state fell outside federal jurisdiction. And it contained no requirement that drugs be tested for safety before going on sale. A manufacturer could introduce a completely new, untested substance and only face consequences after people were harmed.

From the 1906 Act to the FDA

The weaknesses of the original law became tragically clear in 1937, when a company dissolved a common antibiotic in a sweet-tasting but toxic solvent and marketed it as “Elixir Sulfanilamide.” More than 100 people died, many of them children. Because the 1906 act had no safety testing requirement, the government could only prosecute the company for misbranding (calling it an “elixir” when it contained no alcohol), not for selling a poison.

The disaster accelerated passage of the Federal Food, Drug, and Cosmetic Act of 1938, which replaced the 1906 law entirely. The 1938 act added sweeping new protections. New drugs had to be proven safe before they could be sold. The requirement to prove a manufacturer’s fraudulent intent was eliminated. The law’s reach expanded to cover cosmetics and medical devices. Federal inspectors gained the authority to enter and examine factories. Courts could issue injunctions to stop violations immediately, rather than relying solely on seizures and criminal prosecution after the fact.

The Bureau of Chemistry’s regulatory work eventually split off into its own agency, which was formally named the Food and Drug Administration in 1930. But the organizational DNA traces directly back to Wiley’s small team of chemists and the 1906 act that first gave the federal government the power to tell Americans what was really in their food and medicine.